BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
🇺🇸United States
Imaging Modalities in Detection of Coronary Artery Disease in End-stage Renal Disease Patients
Completed
- Conditions
- Myocardial InfarctionStrokeCoronary Artery DiseaseDeath
- First Posted Date
- 2008-08-01
- Last Posted Date
- 2023-09-15
- Lead Sponsor
- University of Nebraska
- Target Recruit Count
- 189
- Registration Number
- NCT00726921
- Locations
- 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States
Assess Vitamin D Levels in Those With & Without Thyroid Cancer
Completed
- Conditions
- Thyroid Cancer
- First Posted Date
- 2008-07-21
- Last Posted Date
- 2023-10-16
- Lead Sponsor
- University of Nebraska
- Target Recruit Count
- 111
- Registration Number
- NCT00719615
- Locations
- 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States
Relationship Between Physical Activity and Stem Cells in Older Adults
Completed
- Conditions
- Aging
- First Posted Date
- 2008-06-04
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- University of Nebraska
- Target Recruit Count
- 39
- Registration Number
- NCT00690183
- Locations
- 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States
Specialized Substance Abuse Supervision (SSAS) Versus Non-SSAS Recidivism Rates Among Nebraska Felony Drug Offenders
Completed
- Conditions
- Alcohol-related DisordersSubstance-related Disorders
- First Posted Date
- 2008-06-04
- Last Posted Date
- 2023-09-25
- Lead Sponsor
- University of Nebraska
- Target Recruit Count
- 344
- Registration Number
- NCT00690352
- Locations
- 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States
Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast Cancer
Phase 2
Terminated
- Conditions
- HER2-negative Breast CancerStage IIIC Breast CancerStage II Breast CancerStage IIIB Breast CancerStage IIIA Breast Cancer
- Interventions
- Biological: bevacizumabOther: laboratory biomarker analysisBiological: pegfilgrastim
- First Posted Date
- 2008-05-16
- Last Posted Date
- 2023-12-11
- Lead Sponsor
- University of Nebraska
- Target Recruit Count
- 15
- Registration Number
- NCT00679029
- Locations
- 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States
Autologous Platelet Gel in Wound Healing of Coronary Artery Bypass Grafting (CABG) Patients
Not Applicable
Withdrawn
- Conditions
- InfectionWounds
- Interventions
- Biological: autologous platelet gel
- First Posted Date
- 2008-05-06
- Last Posted Date
- 2023-08-15
- Lead Sponsor
- University of Nebraska
- Registration Number
- NCT00672672
Followup of Glenoid Fix Utilizing Auto Bone Graft in Shoulder Replacement
Completed
- Conditions
- Arthritis
- Interventions
- Procedure: X-rays and CT scan
- First Posted Date
- 2008-05-02
- Last Posted Date
- 2023-09-26
- Lead Sponsor
- University of Nebraska
- Target Recruit Count
- 29
- Registration Number
- NCT00670852
- Locations
- 🇺🇸
University of Nebraska Medical Center, Dept Orthopaedic Surgery, Omaha, Nebraska, United States
Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
Completed
- Conditions
- Breast CancerPrecancerous Condition
- First Posted Date
- 2008-04-25
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- University of Nebraska
- Target Recruit Count
- 4945
- Registration Number
- NCT00666731
- Locations
- 🇺🇸
Penrose Cancer Center, Colorado Springs, Colorado, United States
🇺🇸Centura - Porter Adventist Hospital, Denver, Colorado, United States
🇺🇸Centura - St. Anthony Hospital, Lakewood, Colorado, United States
Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery
Phase 2
Terminated
- Conditions
- Breast Cancer
- Interventions
- Biological: filgrastimGenetic: gene expression analysisGenetic: polymorphism analysisGenetic: protein expression analysisGenetic: reverse transcriptase-polymerase chain reactionOther: imaging biomarker analysisOther: immunohistochemistry staining methodOther: laboratory biomarker analysisOther: pharmacogenomic studiesProcedure: dynamic contrast-enhanced magnetic resonance imagingProcedure: needle biopsyProcedure: neoadjuvant therapyProcedure: radiomammographyProcedure: ultrasound imaging
- First Posted Date
- 2008-04-23
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- University of Nebraska
- Target Recruit Count
- 3
- Registration Number
- NCT00665457
- Locations
- 🇺🇸
Unversity of Nebraska Medical Center, Omaha, Nebraska, United States
Pancreatic Cancer Collaborative Registry
Completed
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2008-04-21
- Last Posted Date
- 2023-09-06
- Lead Sponsor
- University of Nebraska
- Target Recruit Count
- 379
- Registration Number
- NCT00661882
- Locations
- 🇺🇸
Eppley Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, United States